{"name":"AMIpharm Co., Ltd.","slug":"amipharm-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Matching placebo of AYP-101","genericName":"Matching placebo of AYP-101","slug":"matching-placebo-of-ayp-101","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Matching placebo of AYP-101","genericName":"Matching placebo of AYP-101","slug":"matching-placebo-of-ayp-101","phase":"phase_3","mechanism":"This is a matching placebo control and contains no active pharmaceutical ingredient.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNNkpZRmdDeEl1QmNhUVNUaU1lZHZQbTNUMEtkcGdPWTRnQmljY2lnLVVBdWh2b1F4R3QtRXNFRXBIMnBwQkJ3T1JTTFJXQUpGX1Itc3o3VENHM1d4Y1JaOUpiZ1VMdThTN3hRVG5wcU93bXIwdXBFSHdDajJnUG11aU5DdVRES003RkttSXhBb1NDTU1fdlBrNFZR?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"South Korea INDs: Pimedbio, Sillajen, Genosco, SK Bio, Ami - BioWorld News","headline":"South Korea INDs: Pimedbio, Sillajen, Genosco, SK Bio, Ami","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}